Report for Israel DI

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (4)

Title : Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT) - Ding_2021_Bioorg.Med.Chem_41_116216
Author(s) : Ding Y , Belyanskaya S , DeLorey JL , Messer JA , Joseph Franklin G , Centrella PA , Morgan BA , Clark MA , Skinner SR , Dodson JW , Li P , Marino JP, Jr. , Israel DI
Ref : Bioorganic & Medicinal Chemistry , 41 :116216 , 2021
Abstract : Ding_2021_Bioorg.Med.Chem_41_116216
ESTHER : Ding_2021_Bioorg.Med.Chem_41_116216
PubMedSearch : Ding_2021_Bioorg.Med.Chem_41_116216
PubMedID: 34023664

Title : Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase - Belyanskaya_2017_Chembiochem_18_837
Author(s) : Belyanskaya SL , Ding Y , Callahan JF , Lazaar AL , Israel DI
Ref : Chembiochem , 18 :837 , 2017
Abstract : Belyanskaya_2017_Chembiochem_18_837
ESTHER : Belyanskaya_2017_Chembiochem_18_837
PubMedSearch : Belyanskaya_2017_Chembiochem_18_837
PubMedID: 28281333

Title : Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase - Thalji_2013_Bioorg.Med.Chem.Lett_23_3584
Author(s) : Thalji RK , McAtee JJ , Belyanskaya S , Brandt M , Brown GD , Costell MH , Ding Y , Dodson JW , Eisennagel SH , Fries RE , Gross JW , Harpel MR , Holt DA , Israel DI , Jolivette LJ , Krosky D , Li H , Lu Q , Mandichak T , Roethke T , Schnackenberg CG , Schwartz B , Shewchuk LM , Xie W , Behm DJ , Douglas SA , Shaw AL , Marino JP, Jr.
Ref : Bioorganic & Medicinal Chemistry Lett , 23 :3584 , 2013
Abstract : Thalji_2013_Bioorg.Med.Chem.Lett_23_3584
ESTHER : Thalji_2013_Bioorg.Med.Chem.Lett_23_3584
PubMedSearch : Thalji_2013_Bioorg.Med.Chem.Lett_23_3584
PubMedID: 23664879
Gene_locus related to this paper: human-EPHX2

Title : In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor - Podolin_2013_Prostaglandins.Other.Lipid.Mediat_104-105_25
Author(s) : Podolin PL , Bolognese BJ , Foley JF , Long E, 3rd , Peck B , Umbrecht S , Zhang X , Zhu P , Schwartz B , Xie W , Quinn C , Qi H , Sweitzer S , Chen S , Galop M , Ding Y , Belyanskaya SL , Israel DI , Morgan BA , Behm DJ , Marino JP, Jr. , Kurali E , Barnette MS , Mayer RJ , Booth-Genthe CL , Callahan JF
Ref : Prostaglandins Other Lipid Mediat , 104-105 :25 , 2013
Abstract : Podolin_2013_Prostaglandins.Other.Lipid.Mediat_104-105_25
ESTHER : Podolin_2013_Prostaglandins.Other.Lipid.Mediat_104-105_25
PubMedSearch : Podolin_2013_Prostaglandins.Other.Lipid.Mediat_104-105_25
PubMedID: 23434473